ARGATROBAN Injection in 0.9% Sodium Chloride 250 mg/250 recall: CGMP Deviations
ARGATROBAN Injection in 0.9% Sodium Chloride 250 mg/250 mL (1 mg/mL) , Rx Only, Manufactured in Hungary for TEVA PHARMACEUTICALS USA, INC., North…
Why was ARGATROBAN Injection in 0.9% Sodium Chloride 250 mg/250 recalled?
CGMP Deviations
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
All lots within Expiry. Lot # 4720915, 6790315, 6800315, 6810315, 6820315
- Product
- ARGATROBAN Injection in 0.9% Sodium Chloride 250 mg/250 mL (1 mg/mL) , Rx Only, Manufactured in Hungary for TEVA PHARMACEUTICALS USA, INC., North…
- Recalling firm
- Teva North America
- Quantity
- 1,299 bags
- Distribution
- Nationwide and Puerto Rico
- Recall date
- September 14, 2016
- Classification
- Class II
- Status
- Terminated
- Agency
- FDA (drug)